Cargando…
Dexamethasone inhibits the proliferation of tumor cells
OBJECTIVE: Dexamethasone (DEX) is a glucocorticoid that is commonly used in clinics. Previously, DEX has been shown to inhibit the function of immune system; however, DEX is often used to treat side reactions, such as nausea and vomiting caused by chemotherapy in clinics. Therefore, it is necessary...
Autores principales: | Wu, Yuantao, Xia, Rui, Dai, Chungang, Yan, Suji, Xie, Tao, Liu, Bing, Gan, Lei, Zhuang, Zhixiang, Huang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362917/ https://www.ncbi.nlm.nih.gov/pubmed/30774442 http://dx.doi.org/10.2147/CMAR.S187659 |
Ejemplares similares
-
KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells
por: Jiang, Meng, et al.
Publicado: (2017) -
Androgen receptor reverts dexamethasone-induced inhibition of prostate cancer cell proliferation and migration
por: Guo, Ju, et al.
Publicado: (2018) -
N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
por: Zheng, Xin, et al.
Publicado: (2023) -
Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro
por: Shao, Lili, et al.
Publicado: (2021) -
High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression
por: Xu, Lei, et al.
Publicado: (2020)